A detailed history of National Bank Of Canada transactions in Coll Plant Biotechnologies LTD stock. As of the latest transaction made, National Bank Of Canada holds 250 shares of CLGN stock, worth $860. This represents 0.0% of its overall portfolio holdings.

Number of Shares
250
Previous 250 -0.0%
Holding current value
$860
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 13, 2022

BUY
$6.3 - $9.99 $1,575 - $2,497
250 New
250 $2,000

Others Institutions Holding CLGN

About CollPlant Biotechnologies Ltd


  • Ticker CLGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,086,500
  • Market Cap $38.1M
  • Description
  • CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering tech...
More about CLGN
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.